0001415889-23-000291.txt : 20230104
0001415889-23-000291.hdr.sgml : 20230104
20230104161408
ACCESSION NUMBER: 0001415889-23-000291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russo Rene
CENTRAL INDEX KEY: 0001722066
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 23506528
MAIL ADDRESS:
STREET 1: C/O ARSANIS, INC.
STREET 2: 890 WINTER STREET, SUITE 230
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-01042023_090151.xml
X0306
4
2023-01-01
0001840233
Xilio Therapeutics, Inc.
XLO
0001722066
Russo Rene
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
true
true
false
false
CEO
Stock Option (right to buy)
2.69
2023-01-01
4
A
0
350000
0
A
2032-12-31
Common Stock
350000
350000
D
The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until January 1, 2027.
/s/ Chris Frankenfield, Attorney-in-Fact
2023-01-04